Atavistik Bio Revenue and Competitors

Location

#8358

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Atavistik Bio's estimated annual revenue is currently $3.2M per year.(i)
  • Atavistik Bio's estimated revenue per employee is $85,878
  • Atavistik Bio's total funding is $100M.

Employee Data

  • Atavistik Bio has 37 Employees.(i)
  • Atavistik Bio grew their employee count by 9% last year.

Atavistik Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Business OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
VP, Head BiologyReveal Email/Phone
5
VP, Head OperationsReveal Email/Phone
6
VP FinanceReveal Email/Phone
7
VP, Biochemistry and BiophysicsReveal Email/Phone
8
Director, Medicinal ChemistryReveal Email/Phone
9
President and Chief Scientific OfficerReveal Email/Phone
10
Senior Office Manager and HR Operations SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M1-50%N/AN/A
#3
$5.1M3322%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M2-60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M290%N/AN/A
Add Company

What Is Atavistik Bio?

Atavistik Bio is a new, privately-held biopharmaceutical company focused on the discovery and development of novel therapies for metabolic diseases and cancer. Our high-throughput platform for the unbiased identification of metabolite-protein interactions will enable the discovery of first-in-class drugs inspired and empowered by nature’s own mechanisms of allosteric control. Our unique approach marries this validated platform with structure-aided drug design capabilities and cutting-edge insights into the regulation of metabolic systems to apply to genetically validated targets.

keywords:N/A

$100M

Total Funding

37

Number of Employees

$3.2M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M37-39%$60M
#2
$4.3M3732%N/A
#3
$15M37-18%N/A
#4
$4.1M3716%N/A
#5
$3.5M37-5%N/A